ClearPoint Neuro (CLPT) EBIT Margin Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) EBIT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 146.00 |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn | -3,252.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,252.00 |
| Mar 31, 2026 | 273.00 |
| Dec 31, 2025 | 485.00 |
| Sep 30, 2025 | 396.00 |
| Jun 30, 2025 | -152.00 |
| Mar 31, 2025 | -1,744.00 |
| Dec 31, 2024 | -342.00 |
| Sep 30, 2024 | 2,148.00 |
| Jun 30, 2024 | 5,973.00 |
| Mar 31, 2024 | 4,994.00 |
| Dec 31, 2023 | 1,727.00 |
| Sep 30, 2023 | -1,124.00 |
| Jun 30, 2023 | -3,900.00 |
| Mar 31, 2023 | -2,833.00 |
| Dec 31, 2022 | 662.00 |
| Sep 30, 2022 | 942.00 |
| Jun 30, 2022 | 1,898.00 |
| Mar 31, 2022 | -2,268.00 |
| Dec 31, 2021 | -3,204.00 |
| Sep 30, 2021 | -4,702.00 |